Insulin aspart, recombinant Subcutaneous and LMD Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and LMD Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: dextran, low molecular weight
Brand name: LMD
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-LMX 4 Topical application
- Insulin aspart, recombinant Subcutaneous-LMX 5
- Insulin aspart, recombinant Subcutaneous-LMX 5 Topical application
- Insulin aspart, recombinant Subcutaneous-Lo Loestrin Fe
- Insulin aspart, recombinant Subcutaneous-Lo Minastrin Fe
- Insulin aspart, recombinant Subcutaneous-Lo Minastrin Fe birth control
- LMD Injection-Insulin degludec
- LMD Injection-Insulin Degludec (U-100) Prefilled Pens
- LMD Injection-Insulin Degludec (U-100) Vials
- LMD Injection-Insulin Degludec (U-200) Prefilled Pens
- LMD Injection-Insulin degludec and liraglutide
- LMD Injection-Insulin degludec and liraglutide Subcutaneous